Related Experiment Video
Updated: Aug 3, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
[Multiple sclerosis treatments]
1Service de neurologie, Centre hospitalier universitaire François-Mitterrand Dijon Bourgogne, 2B boulevard Maréchal-de-Lattre-de-Tassigny, 21000 Dijon, France; Centre de ressources et de compétences sclérose en plaques Bourgogne-Franche-Comté, Centre hospitalier universitaire François-Mitterrand Dijon Bourgogne, 2B boulevard Maréchal-de-Lattre-de-Tassigny, 21000 Dijon, France.
Abstract:
The last thirty years have led to the introduction of treatments that reduce the frequency of relapses and slow the progression of multiple sclerosis. They must be prescribed early, chosen according to the form of the disease and actively monitored. Symptomatic treatments complete the treatment.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Alzheimer's Disease: Treatment
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...

